Clinical Trials Directory

Trials / Completed

CompletedNCT04597320

Esketamine Sedation and Fentanyl Sedation in Pediatric Dental Patients

The Effects of Esketamine Sedation Compared With Fentanyl Sedation in Pediatric Dental Patients: A Double Blind, Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Peking University · Academic / Other
Sex
All
Age
6 Years – 14 Years
Healthy volunteers
Not accepted

Summary

Since the 1970s, ketamine has been used in clinical anesthesia treatment. Compared with ketamine, esketamine has a higher clearance rate, so it has a shorter recovery time after anesthesia. This feature also makes ketamine more suitable for pediatric dental patients.The purpose of this study was to investigate and compare the efficacy of esketamine sedation and fentanyl sedation in pediatric dental patients

Conditions

Interventions

TypeNameDescription
DRUGFentanylThe fentanyl group was prepared by 1ug/kg fentanyl in 5ml normal saline, assembled with 5ml injection, labeled as "Anesthesia inducer".
DRUGEsketamineThe esketamine group was prepared by 0.5mg/kg esketamine in 5ml normal saline, assembled with 5ml injection, labeled as "Anesthesia inducer".
DRUGMidazolamMidazolam 0.05mg/kg+ "Anesthesia inducer" was applied to all patients for procedural induction by intravenous injection. According to the MOAA/S score of the patients, midazolam could be added 0.5mg per time at more than 2 minutes until the MOAA/S score reached 3, the maximum infusion dose of midazolam was less than 10mg and less than 0.1mg/kg.

Timeline

Start date
2022-01-01
Primary completion
2022-02-28
Completion
2022-03-12
First posted
2020-10-22
Last updated
2022-03-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04597320. Inclusion in this directory is not an endorsement.

Esketamine Sedation and Fentanyl Sedation in Pediatric Dental Patients (NCT04597320) · Clinical Trials Directory